Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Auron Therapeutics, Inc.Startup |
Active Organization Auron Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Discovery | US | Auron Therapeutics, Inc.Startup | 18 Mar 2024 |
Colorectal Cancer | Discovery | US | Auron Therapeutics, Inc.Startup | 18 Mar 2024 |
Neuroblastoma | Discovery | US | Auron Therapeutics, Inc.Startup | 18 Mar 2024 |
Neuroendocrine Tumors | Discovery | US | Auron Therapeutics, Inc.Startup | 18 Mar 2024 |
Non-Small Cell Lung Cancer | Discovery | US | Auron Therapeutics, Inc.Startup | 18 Mar 2024 |
Prostate Neuroendocrine Carcinoma | Discovery | US | Auron Therapeutics, Inc.Startup | 18 Mar 2024 |
Small Cell Lung Cancer | Discovery | US | Auron Therapeutics, Inc.Startup | 18 Mar 2024 |